Improving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE Network
Forecasted
This grant funds research sites to improve influenza and respiratory pathogen vaccine effectiveness through surveillance, coordination, household transmission, and immunogenicity studies in the US Flu VE Network.
Funder: Centers for Disease Control and Prevention - ERA
Due Dates (Anticipated): December 2026 (Full application deadline)
Funding Amounts: Estimated total: $75,250,000 | Typical award: $1,350,000–$3,550,000 per year depending on component; up to 6 awards expected
Summary: Supports research and surveillance to improve the effectiveness of influenza and other respiratory pathogen vaccines through the US Flu VE Network.
Key Information: Forecasted opportunity; all deadlines are projected and subject to change.
Description
This opportunity aims to continue and expand the US Influenza Vaccine Effectiveness (Flu VE) Network. The network provides critical data to improve the effectiveness of influenza and other respiratory pathogen vaccines by supporting multi-site research and surveillance activities. Funded projects will conduct annual vaccine effectiveness (VE) and correlates of protection surveillance, electronic acute respiratory illness and VE surveillance, household transmission research, and immunogenicity studies. The program is divided into components (A–D), with applicants required to apply for either Component A (VE and correlates of protection) or B (Coordination and surge capacity), and optional participation in Components C (Household transmission studies) and D (Immunogenicity studies) depending on the primary component selected.
